15TH<\/sup> EUROPEAN BREAST CANCER CONFERENCE<\/h1><\/div>25-27 March 2026<\/span>, Barcelona, Spain<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>Call for abstracts<\/span><\/h2><\/div>General Information<\/h4><\/div>Abstracts submitted for presentation in EBCC-15 will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted.<\/p>\n
The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee.
\nAbstracts submitted after the stipulated deadline will not be considered.<\/p>\n
Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.<\/p>\n
In case of any abstract related queries please contact: ebcc@eortc.org<\/a>.<\/p>\n<\/div><\/div><\/div>![\"Call](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EBCC-15-Abstract-Image.png\" "\\"Call")
<\/span><\/div><\/div><\/div><\/div>Abstract submission: 1 September \u2013 3 November 2025
\nLate-breaking submission: 2-9 February 2026
\nALL SUBMISSIONS NOW CLOSED<\/strong><\/div>\n<\/div>Abstract Submission: 1 September – 3 November 2025<\/h4><\/div>Late-breaking submission: 2-9 February 2026<\/h4><\/div><\/div><\/div><\/div><\/div>Submit your late breaker<\/span><\/a><\/div>- <\/i><\/span>LBA Policy<\/a><\/div><\/li>
- <\/i><\/span>Abstract policy<\/a><\/div><\/li>
- <\/i><\/span>\n
Poster Guidelines<\/a><\/p>\n<\/div><\/li>- <\/i><\/span>\n
Speaker Guidelines<\/a><\/p>\n<\/div><\/li>- <\/i><\/span>\n
PPT Template<\/a><\/p>\n<\/div><\/li><\/ul>Abstract Policy<\/span><\/a><\/div>LBA Policy<\/span><\/a><\/div>Poster Guidelines<\/span><\/a><\/div><\/div><\/div><\/div><\/div>Late Breaking Abstracts<\/h4><\/div>Submissions closed.<\/p>\n<\/div>
Abstract Submission Deadline: 3 November<\/h4><\/div>Presentation Formats<\/h4><\/div><\/div><\/div><\/div><\/div><\/div>Oral Presentation<\/h5><\/div>Abstracts of superior quality can be selected for presentation in a session where discussants will place the research findings into perspective.<\/p>\n<\/div><\/div><\/div>
Poster in the Spotlight Sessions<\/h5><\/div>The Scientific Committee will make a special selection of posters which will be highlighted through short oral presentations followed by moderated discussion.<\/p>\n
These sessions will facilitate dynamic exchange on selected findings of broad interest.<\/p>\n<\/div><\/div><\/div>
Poster Presentation<\/h5><\/div>Abstracts that have been selected for poster presentation will be displayed on poster boards in a prominent poster viewing area.<\/p>\n
The posters will be grouped by topic and displayed for one day.<\/p>\n
A specific time will be devoted to poster viewing to ensure delegates have sufficient opportunity to acquaint themselves with the presented data.<\/p>\n<\/div><\/div><\/div><\/div>
Abstract Topic Categories<\/h4><\/div>- <\/i><\/span>\n
Advocacy<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Basic Science and Translational Research<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Genetics<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Lifestyle\/Prevention including Secondary Prevention<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Local Regional Treatment – Radiotherapy<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Local Regional Treatment – Surgery
\nNeoadjuvant Treatments<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Optimal Diagnosis<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Precision Medicine<\/p>\n<\/div><\/li><\/ul><\/div><\/div>
- <\/i><\/span>\n
Rehabilitation\/Survivorship\/FollowUp<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Risk Factors<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Screening<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Supportive and Palliative Care including end of life treatmentSupportive and Palliative Care including end of life treatment<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Systemic Treatment including immunotherapy, ADCs, CDKs etc: Advanced Disease<\/p>\n<\/div><\/li>
- <\/i><\/span>\n
Systemic Treatment including immunotherapy, ADCs, CDKs etc: Early Disease<\/p>\n<\/div><\/li><\/ul><\/div><\/div>
<\/div><\/div><\/div>The copyright of the abstract(s) are retained by the author(s).
\nHowever, the author(s) give permission to the EBC Council to print the abstract(s) in the EJC as well as on the EBCC-15 website.<\/p>\n
Submitting an abstract for presentation in EBCC-15 does not constitute registration for the conference. When selected, abstract presenters must register to attend EBCC-15.<\/p>\n
Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.
\nIn case of any abstract related queries please contact: ebcc@eortc.org<\/a>.<\/p>\n<\/div><\/div><\/div>\n\n\n\n\nPartners
\nEBCCouncil<\/span><\/h3>\n<\/td>\n![](\"\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EBCC-Council-logo.png\")
<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n![\"EORTC](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EORTC_BCG_828x275_2018.png\" "\\"EORTC")
<\/span><\/div>![\"Eusoma](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/EUSOMA_LOGO.png\" "\\"Eusoma")
<\/span><\/div>![\"Europa](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/europa-donna.png\" "\\"Europa")
<\/span><\/div><\/div><\/div>Download the
\nConference App<\/span><\/p><\/h3><\/div>The EBCC-15 app is a powerful tool designed to enhance your experience during EBCC-15.<\/p>\n
25-27 March 2026<\/span>, Barcelona, Spain<\/span><\/p>\n<\/div><\/div><\/div> Abstracts submitted for presentation in EBCC-15 will be reviewed by an international panel of experts in the field of the subject and will be judged solely on the data submitted.<\/p>\n The final decision on the presentation format of all selected abstracts lies at the sole discretion of the Scientific Committee. Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract.<\/p>\n In case of any abstract related queries please contact: ebcc@eortc.org<\/a>.<\/p>\n<\/div><\/div><\/div> Poster Guidelines<\/a><\/p>\n<\/div><\/li> Speaker Guidelines<\/a><\/p>\n<\/div><\/li> PPT Template<\/a><\/p>\n<\/div><\/li><\/ul> Submissions closed.<\/p>\n<\/div> Abstracts of superior quality can be selected for presentation in a session where discussants will place the research findings into perspective.<\/p>\n<\/div><\/div><\/div> The Scientific Committee will make a special selection of posters which will be highlighted through short oral presentations followed by moderated discussion.<\/p>\n These sessions will facilitate dynamic exchange on selected findings of broad interest.<\/p>\n<\/div><\/div><\/div> Abstracts that have been selected for poster presentation will be displayed on poster boards in a prominent poster viewing area.<\/p>\n The posters will be grouped by topic and displayed for one day.<\/p>\n A specific time will be devoted to poster viewing to ensure delegates have sufficient opportunity to acquaint themselves with the presented data.<\/p>\n<\/div><\/div><\/div><\/div> Advocacy<\/p>\n<\/div><\/li> Basic Science and Translational Research<\/p>\n<\/div><\/li> Genetics<\/p>\n<\/div><\/li> Lifestyle\/Prevention including Secondary Prevention<\/p>\n<\/div><\/li> Local Regional Treatment – Radiotherapy<\/p>\n<\/div><\/li> Local Regional Treatment – Surgery Optimal Diagnosis<\/p>\n<\/div><\/li> Precision Medicine<\/p>\n<\/div><\/li><\/ul><\/div><\/div> Rehabilitation\/Survivorship\/FollowUp<\/p>\n<\/div><\/li> Risk Factors<\/p>\n<\/div><\/li> Screening<\/p>\n<\/div><\/li> Supportive and Palliative Care including end of life treatmentSupportive and Palliative Care including end of life treatment<\/p>\n<\/div><\/li> Systemic Treatment including immunotherapy, ADCs, CDKs etc: Advanced Disease<\/p>\n<\/div><\/li> Systemic Treatment including immunotherapy, ADCs, CDKs etc: Early Disease<\/p>\n<\/div><\/li><\/ul><\/div><\/div> The copyright of the abstract(s) are retained by the author(s). Submitting an abstract for presentation in EBCC-15 does not constitute registration for the conference. When selected, abstract presenters must register to attend EBCC-15.<\/p>\n Authors are strongly advised to submit prior to the deadline and avoid unnecessary delays which may affect the standing of their abstract. Download the The EBCC-15 app is a powerful tool designed to enhance your experience during EBCC-15.<\/p>\nCall for abstracts<\/span><\/h2><\/div>
General Information<\/h4><\/div>
\nAbstracts submitted after the stipulated deadline will not be considered.<\/p>\n<\/span><\/div><\/div><\/div><\/div>
\nLate-breaking submission: 2-9 February 2026
\nALL SUBMISSIONS NOW CLOSED<\/strong><\/div>\n<\/div>Abstract Submission: 1 September – 3 November 2025<\/h4><\/div>
Late-breaking submission: 2-9 February 2026<\/h4><\/div><\/div><\/div>
Late Breaking Abstracts<\/h4><\/div>
Abstract Submission Deadline: 3 November<\/h4><\/div>
Presentation Formats<\/h4><\/div><\/div><\/div>
Oral Presentation<\/h5><\/div>
Poster in the Spotlight Sessions<\/h5><\/div>
Poster Presentation<\/h5><\/div>
Abstract Topic Categories<\/h4><\/div>
\nNeoadjuvant Treatments<\/p>\n<\/div><\/li>
\nHowever, the author(s) give permission to the EBC Council to print the abstract(s) in the EJC as well as on the EBCC-15 website.<\/p>\n
\nIn case of any abstract related queries please contact: ebcc@eortc.org<\/a>.<\/p>\n<\/div><\/div><\/div>\n\n
\n \n Partners
\nEBCCouncil<\/span><\/h3>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/span><\/div><\/span><\/div><\/span><\/div><\/div><\/div>
\nConference App<\/span><\/p><\/h3><\/div>
![\"Google](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/Image-2.png\" "\\"Google")
<\/span><\/div>![\"Apple](\"https:\/\/event.eortc.org\/ebcc15\/wp-content\/uploads\/sites\/35\/2025\/01\/Image-1.png\" "\\"Apple")
<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-315","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages\/315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/comments?post=315"}],"version-history":[{"count":0,"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/pages\/315\/revisions"}],"wp:attachment":[{"href":"https:\/\/event.eortc.org\/ebcc15\/wp-json\/wp\/v2\/media?parent=315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}